JAK/HDAC-IN-2 is a potent dual JAK/HDAC inhibitor with pro-apoptotic activity; it significantly inhibits histone deacetylation and STAT3 phosphorylation, and exhibits marked anti-proliferative activity in both hematological malignancies and solid tumors.